Edmund Reese
Analyst · Evercore ISI
Thanks, Tim, and good morning, everyone. As you can see from the Q3 financial summary on Slide 7, Broadridge delivered another strong quarter. Recurring revenue grew 8% to $900 million. Adjusted operating income also grew 8% to $284 million. Margins declined 60 basis points to 20.4% as we successfully made the investments that we discussed last quarter in our technology platforms, in our products, our people. Our operating income was partially offset by a higher tax rate in Q3 '21 as we grew over discrete tax benefits in Q3 '20. So our adjusted EPS grew to $1.76 in the quarter, up 5% over Q3 '20.
Now let's turn the slide and get into the details of the quarter, starting with recurring revenue growth. As I said, recurring revenue grew 8% in the quarter, powered by 7% organic growth, and comfortably within our historic mid- to high single-digit growth performance. demonstrating the strength of our sustainable recurring revenue growth model. As a result of that strong organic growth and an increase in our outlook for the fourth quarter, we're raising our guidance for recurring revenue growth to 8% to 10% for the full year, up from our prior guidance of growth at the higher end of 3% to 6%.
Now let's look at this quarter's recurring revenue growth by business on Slide 9. I'll start with our ICS segment, where revenues grew by 11% to $586 million. Regulatory revenues rose 20% to $290 million driven by the 20% equity record growth, higher mutual fund and ETF communications volumes and net new sales, including from our Shareholder Rights Directive II solution that Tim highlighted earlier. We expect strong regulatory revenue growth to continue in the fourth quarter with, our current testing indicating 25% equity record growth.
Our Issuer business also contributed to our overall growth rate, thanks to continued growth in VSMs and increased issuer communications. After a strong 12 months, we now have significant penetration of our VSM solution across the S&P 500, and we expect issuer revenue growth to ease going forward as we start to lap the increase of VSM activity that began in Q4 '20.
Fund solutions revenue was flat as double-digit growth in data and analytics was offset by lower interest income from custodied accounts in our funds processing business. Customer communications revenues were also flat with double-digit growth in our high-margin digital products, offset by lower print volumes due in part to the pandemic-depressed activity levels. We expect growth in both our data-driven solutions and customer communications business to pick up in the fourth quarter as these headwinds ease.
Turning to GTO. Wealth and investment management revenues rose 7%, driven by the onboarding of new component sales and higher retail trading. Capital markets revenues fell 1% as strong growth from international sales, was offset by $6 million in lower license revenues, which declined as expected. As we said last quarter, this flat revenue growth will continue in the Q4 '21 before picking up in fiscal year '22.
Let's turn to Page 10, where we show more detail on volume trends. Broadridge's recurring revenue growth benefits from underlying volume growth trends, including stock record growth. Over the past decade, record growth across equity, mutual funds and ETF has grown 6% to 8%. Recently, equity record growth has accelerated to 11% in Q4 '20 and continued to increase through the year to 20% in Q3 '21, surpassing the estimates from our January testing. As I said, we expect these growth trends to continue and reach 25% in Q4 '21.
Mutual fund and ETF record growth picked up as well to 7%, more in line with our historical growth rates. We are modeling a return to more moderate mid-single-digit growth across both equity, mutual fund ETF records for fiscal year '22, with stronger growth in the seasonally smaller first half and more moderate growth in the second half.
Touching briefly on trade volumes, which you'll see on the bottom of this slide. This is the fifth consecutive quarter of aggregate double-digit volume growth. This growth reflects the increase in volatility in retail investor engagement over the past year, which continued to be quite strong well into the third quarter. More recently, trading volatility subsided during the second half of March, and we expect tougher trading volume comps in Q4.
Let's move to Slide 11 for a closer look at the drivers of our recurring revenue. Organic growth at a very healthy 7% continues to be the largest component of our recurring revenue growth, and new sales remains the biggest driver with strong growth contribution from both ICS and GTO. We also continued our long track record of revenue retention above 97%. Internal growth contributed another 3 points as growth in ICS regulatory volumes more than offset the decline in GTO license revenue. And finally, acquisitions. We've now fully lapped all of our fiscal year 2020 acquisitions. Looking ahead to the fourth quarter, we expect Itiviti to add 3 points to fourth quarter recurring revenue growth.
Now we'll turn to Slide 12 to briefly touch on our total revenue performance. Total revenue growth this quarter was stronger than usual, reaching 11%, with distribution revenue contributing 3 points due to the increased mailings that correspond with the high record growth and the increased event-driven activity this quarter. Moving forward, we continue to expect the low to no-margin distribution revenue to decline over time as we focus on increasing higher-margin digital revenue across our governance business.
Event-driven communications remain an integral part of our client offering. Event-driven revenues have climbed over the past 4 quarters to be more in line with our historical norms of about $50 million a quarter and reached $74 million in the third quarter, well above last year's unusually low $39 million. Broadridge benefited from an increase in mutual fund proxy activity as well as a rebound in proxy contest volumes and capital markets transactions. We expect fiscal '21 event-driven revenue to be more in line with the average that we've seen over the past 7 years. For modeling purposes, we're assuming $50 million to $60 million of event-driven revenues in the fourth quarter.
Turning to Slide 13. Adjusted operating income grew by 8%. Our adjusted operating income margin declined by 60 basis points, reflecting the continued investments that we're making in our technology platforms and product capabilities that we highlighted on our last quarterly call. These investments, which support our long-term growth, have a short-term impact on margin expansion, but we remain on track to deliver approximately 50 basis points of margin expansion for the full year, right in line with our fiscal year '21 guidance and 3-year growth objectives. This formula, forgoing near-term margin expansion and consistently investing in our technology platforms and products to drive long-term sustainable recurring revenue growth, will continue to be an important part of how we manage our business. As a CFO focused on long-term growth, it's encouraging to see us making these types of investments across all of our product lines, giving us momentum towards future growth.
Before I turn to capital allocation, let's turn to Slide 14 and spend a moment on another key operating metric, closed sales, which, as I mentioned earlier, is the most consistent driver of our long-term recurring revenue growth. Our $124 million closed sales year-to-date are in line with our performance over the same period last year. We continue to see strong demand for our ICS solutions, including regulatory and issuer communications and data solutions.
We remain on track to achieve our full year guidance of $190 million to $235 million for closed sales, which implies a fourth quarter range of $66 million to $111 million. Historically, the closed sales performance in the last quarter of the year has been impacted by the timing of larger deals. A handful of larger signings could propel us to the top end of our guidance range, and conversely, delays could put us at the lower end. And I'll also note that we continue to feel good about our recurring revenue backlog, which was 12% of our fiscal '20 recurring revenues as of Q4 '20 and gives us great visibility into our top line growth.
Moving to capital allocation on the following slide. We generated $136 million of free cash flow year-to-date, up $54 million over the first 9 months of fiscal year '20 driven by higher earnings and strong working capital management. During the first 9 months of the fiscal year, we invested $205 million in building out our industry platforms and another $71 million in CapEx and software spending. Our M&A investment through the first 9 months of the year was 0, but that will change with our announced $2.5 billion acquisition of Itiviti, which I'll touch on in a moment. Even after completing the Itiviti acquisition, Broadridge will remain committed to a balanced capital allocation policy, which prioritizes internal investment, growing our dividend, M&A and returning excess capital to shareholders.
Importantly, we are also committed to maintaining an investment-grade credit rating, which means we'll prioritize debt paydown over share repurchases and expect to limit ourselves to smaller tuck-in M&A opportunities over the next several quarters. Given our strong free cash flow, we believe that we can comfortably achieve our new 2.5x leverage target by the end of fiscal year '23. Turning to capital returns on the right-hand side of the slide, our dividend has grown and remains in line with our historical 45% payout ratio.
On Slide 16, we are on track to close the Itiviti acquisition in the coming weeks. So let me take a moment to give you some additional clarity about the expected impact that Itiviti will have on our financial performance. I'll start with fiscal year '21. We expect Itiviti to add $25 [ billion ] to $30 [ billion ] or 1 point to our full year recurring revenue growth, which equates to 3 points to our fourth quarter growth. And the acquisition is expected to be modestly dilutive to our adjusted EPS growth. In fiscal year '22, we expect Itiviti to add approximately $250 million or about 8 points to our recurring revenue growth. And we expect the acquisition to be accretive by approximately 2 to 3 points or roughly $0.10 to $0.15 to adjusted EPS growth. Please note that Itiviti's results in both fiscal year '21 and fiscal year '22 will be negatively impacted by the accounting treatment of acquired revenue, which will reduce revenue recognition by approximately $30 million in total with 2/3 of that impact in fiscal '22. This revenue haircut is incorporated in the numbers that I just shared with you.
Finally, I want to reiterate the commentary that I gave you when we announced the deal, about the impact on our 3-year growth objectives. We expect Itiviti to add 2.5 to 3 points to our 3-year recurring revenue growth CAGR and, after interest, more than 2 points to our 3-year adjusted EPS CAGR.
Now turning to guidance on Slide 17. We are raising our outlook for fiscal '21 recurring revenue growth to 8% to 10% from the higher end of 3% to 6%, and that includes one point of growth from Itiviti. We are raising our guidance for total revenue growth to 8% to 10% from the higher end of 1% to 4%. We continue to expect our adjusted operating income margin to expand to approximately 18%, up from 17.5% in fiscal year '20 as we balance near-term returns with continued investments to sustain long-term growth. We expect adjusted EPS growth of 11% to 13%, up from the higher end of 6% to 10%, and that includes a 1-point drag from Itiviti.
Finally, as I noted earlier, we continue to expect closed sales in the range of $190 million to $235 million. And before we begin to take your questions, let me share some final thoughts. The Broadridge Financial model is working. We are on track to deliver strong 8% to 10% recurring revenue growth. That growth is fueling our ability to both invest and expand margins. At the same time, our strong free cash flow business model enables us to pursue balanced capital allocation, commit to a rising dividend, fund investments in our platform and products and step up and make a significant M&A investment to grow our capital markets franchise. And finally, thanks to our consistent investment in our capabilities, we are on track to deliver another year of $190 million plus of new closed sales, which, combined with our strong backlog, positions us well for additional recurring revenue growth. The end result is that we're on track to deliver at the higher end of our 3-year financial objectives of 7% to 9% recurring revenue growth and 8% to 12% adjusted EPS growth. It's a great example of how we manage our business to drive sustainable revenue growth, steady and consistent adjusted EPS growth and historically top quartile TSR.
Let me now hand the call back to Andrea to take your questions. Andrea?